Australia Advises 475,000 Bowel Cancer Retests After Kits Questioned
This article was originally published in PharmAsia News
Executive Summary
Australia's Health Department has advised nearly half a million patients to undergo new tests for bowel cancer after kits they used came under question. The department said the tests in question, supplied by Dorevitch Pathology, returned a possibly excessive amount of negative results. Suspicions were raised about the test when the level of positive results, more than 100,000 since last December, was lower than expected. The government plans to notify the 475,000 people who have used the self-test bowel kits since Dec. 1, 2008, advising them to be retested. (Click here for more
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.